文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > 生物学 > Genetic engineering of human pluripotent cells using TALE nucleases
侵权投诉

Genetic engineering of human pluripotent cells using TALE nucleases

briEf communicATions

Genetic engineering of human pluripotent cells using TALE nucleases

Dirk Hockemeyer1,4, Haoyi Wang1,4, Samira Kiani1,

Christine S Lai1,2, Qing Gao1, John P Cassady1,2, Gregory J Cost3, Lei Zhang3, Yolanda Santiago3, Jeffrey C Miller3, Bryan Zeitler3, Jennifer M Cherone3, Xiangdong Meng3, Sarah J Hinkley3, Edward J Rebar3, Philip D Gregory3, Fyodor D Urnov3 & Rudolf Jaenisch1,2

Targeted genetic engineering of human pluripotent cells is a prerequisite for exploiting their full potential. Such genetic manipulations can be achieved using site-specific nucleases. Here we engineered transcription activator–like effector nucleases (TALENs) for five distinct genomic loci. At all loci tested we obtained human embryonic stem cell (ESC) and

induced pluripotent stem cell (iPSC) clones carrying transgenic cassettes solely at the TALEN-specified location. Our data suggest that TALENs employing the specific architectures described here mediate site-specific genome modification in human pluripotent cells with similar efficiency and precision as do zinc-finger nucleases (ZFNs).

Gene targeting of human pluripotent cells by homologous recombination is inefficient, which has impeded the use of human ESCs and iPSCs in disease models. To overcome this limitation, we and others have shown that ZFNs can be used to modify the genomes of ESCs and iPSCs1–3. ZFNs can be engineered to induce a double-strand break precisely at a predetermined position in the genome4. The double-strand break can be repaired through nonhomologous end-joining to drive targeted gene disruption or through the homology-directed DNA repair pathway using an exogenous donor plasmid as a template. Depending on the donor design, this repair reaction can be used to generate large-scale deletions, gene disruptions, DNA addition4 or single-nucleotide changes5.

Recent work on transcription activator–like effectors (TALEs) provides an alternative approach to the design of site-specific nucleases6. Natural TALEs are transcription factors used by plant pathogens to subvert host genome regulatory networks6. The DNA-binding domain of TALEs is unusual. Multiple units of ~34 amino acids (called TALE repeats) are arranged in tandem, their sequence nearly identical except for two highly variable amino acids that establish the base-recognition specificity of each unit7,8. Each individual domain determines the specificity of binding to one DNA base pair in the TALE recognition sequence, and there-fore arrays of four different repeat units are sufficient to generate TALEs with novel DNA recognition sites7,8. Nucleases based on such engineered TALE domains have been shown to target endogenous genes in trans-

formed human cells9,10. Here we evaluate the use of TALENs for genetic engineering of endogenous loci in human ESCs and iPSCs.

We designed TALENs targeting the PPP1R12C (the AAVS1 locus), OCT4 (also known as POU5F1) and PITX3 genes at precisely the same positions as targeted earlier by ZFNs2. TALEN expression constructs and corresponding donor plasmids bearing homologous sequences were introduced into ESCs (line WIBR#3)11 and iPSCs (line C1)12 by elec-troporation (Supplementary Fig. 1 and Supplementary Tables 1 and 2). Southern blot analysis was used to identify correctly targeted clones.We targeted PPP1R12C with a gene trap approach (expressing puro-mycin (Puro) from the endogenous gene; Fig. 1a,b and Table 1) or with an autonomous selection cassette (puromycin expressed from the PGK-promoter (Fig. 1, Table 1 and Supplementary Figs. 1–3). Targeting efficiency was high and similar to that with ZFNs2: 50% of the clones were targeted in one or both alleles and carried no randomly integrated transgenes (Fig. 1b, Table 1 and Supplementary Fig. 2). Similarly, an SA-Puro-CAGGS-eGFP transgene was highly expressed from this locus (Fig. 1a and Supplementary Fig. 3a,b). Notably, such targeted cells remained pluripotent based on analysis of marker expression and of tera-tomas. (Supplementary Fig. 3c–e). Cells of all germ layers in teratomas expressed eGFP, indicating that TALEN- as well as ZFN-mediated target-ing of PPP1R12C results in robust transgene expression in pluripotent as well as in differentiated cells (Supplementary Fig. 3a,b,d,e).

OCT4 was targeted using three different donor plasmids, resulting in expression of puromycin and an OCT4 exon1-eGFP fusion protein under control of the endogenous OCT4 promoter. The first two donor plasmids were designed to integrate a splice acceptor-eGFP-2A-Puro cassette into the first intron of OCT4, whereas the third donor generated an in-frame fusion of exon 1 with the eGFP-2A-Puro cassette (Supplementary Fig. 4). Targeting efficiency in ESCs and iPSCs was 70–100% as determined by Southern blot analysis and DNA sequencing of single cell–derived clones (Table 1 and Supplementary Figs. 1 and 4).

We also targeted the first exon of PITX3, which is not expressed in human pluripotent cells, and found that ~6% of drug-resistant clones carried the transgene solely at the PITX3 locus as evaluated by Southern blot analysis (Table 1 and Supplementary Figs. 1 and 5). Notably, in one clone the transgene had integrated into both alleles of PITX3.

To target the C terminus of OCT4, which has not been previously targeted by ZFNs, we generated TALENs directed against sequences flanking the stop codon of OCT4 using two donor plasmids: the last OCT4 codon was either fused in frame with an eGFP-PGK-Puro con-struct or with eGFP preceded by a 2A sequence (2A-eGFP-PGK-Puro; Fig. 1c and Table 1). After excision of the LoxP-flanked PGK-Puro cas-settes, either a C-terminal OCT4-eGFP fusion protein or a separately translated eGFP protein will be expressed under the control of endog-enous OCT4 (ref. 13). Southern blot analysis showed that 2–10% of single cell–derived ESC and iPSC clones carried the transgene cassette at the OCT4 locus (Fig. 1d,e and Table 1). Cre-mediated excision of the PGK-

© 2011 Nature America, Inc. All rights reserved

Genetic engineering of human pluripotent cells using TALE nucleases

.

Massachusetts, USA.3Sangamo BioSciences, Inc., Richmond, California, USA. 4These authors contributed equally to this work. Correspondence should be addressed to R.J. (jaenisch@wi.mit.edu).

Received 11 March; accepted 28 June; published online 7 July 2011; doi:10.1038/nbt.1927

1The Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA. 2Department of Biology, Massachusetts Institute of Technology, Cambridge,

nature biotechnology volume 29 number 8 august 2011 731

第1页

你可能喜欢

热门文档

相关文档

  • 第二章 工具酶

    transcription activator-like (TAL) effector nucleases Ⅰ 工具酶的功能分类: ...干细胞 《Genetic engineering of human pluripotent cells using TALE nucleases》...

  • Talen_介绍

    ? 一篇人类干细胞 《Genetic engineering of human pluripotent cells using TALE nucleases》 ? 一篇大鼠 《Knockout rats generated by embryo microinjection of ...

  • Talen 讲座 2012-03

    ? 一篇人类干细胞 《Genetic engineering of human pluripotent cells using TALE nucleases》 ? 一篇大鼠 《Knockout rats generated by embryo microinjection of ...

  • 康为世纪TALEN靶向基因敲除讲座

    ? 一篇人类干细胞 《Genetic engineering of human pluripotent cells using TALE nucleases》 ? 一篇大鼠 《Knockout rats generated by embryo microinjection of ...

  • 干细胞和TALEN

    Genetic engineering of human ES and iPS cells using TALE nucleases Dirk ...expression in pluripotent as well as in differentiated cells (Figure S3C–E...

  • Talen 康为世纪

    ? 一篇人类干细胞 《Genetic engineering of human pluripotent cells using TALE nucleases》 ? 一篇大鼠 《Knockout rats generated by embryo microinjection of ...

  • 基因敲除新技术

    ? 一篇人类干细胞 《Genetic engineering of human pluripotent cells using TALE nucleases》 ? 一篇大鼠 《Knockout rats generated by embryo microinjection of ...

  • TALEN技术阳性质粒信息

    Genetic engineering of human pluripotent cells using TALE nucleases[J]. Nature biotechnology, 2011, 29(8): 731-734. 2. 人(miR-155*) : 3. 小鼠:...

  • Talen_康为世纪

    ? 一篇人类干细胞 《Genetic engineering of human pluripotent cells using TALE nucleases》 ? 一篇大鼠 《Knockout rats generated by embryo microinjection of ...

  • Talen_康为世纪

    ? 一篇人类干细胞 《Genetic engineering of human pluripotent cells using TALE nucleases》 ? 一篇大鼠 《Knockout rats generated by embryo microinjection of ...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email